Phase 4 Bipolar Disorder Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with bipolar disorder (type 1 or type 2) and are currently going through a depressive episode, as defined by standard diagnostic guidelines (DSM-5).
- Your depression is scored as at least 21 out of 50 on a self-reported depression questionnaire called the Major Depression Inventory (MDI).
- You have not started or increased the dose of any psychiatric medication (except certain sleep aids or anti-anxiety medicines) in the two weeks before joining.
- You have not started any new formal talking therapy (other than general education about your condition) in the four weeks before joining.
- You are between 18 and 64 years old at the time of joining the trial.
- Your current depressive episode has been going on for between 4 and 52 weeks, as assessed by the doctor running the trial.
- The trial doctor is genuinely uncertain which of the two study medications — cariprazine or lithium — would be better for you specifically.
- If you are a woman who could become pregnant, you must have a negative pregnancy test and be using a reliable form of contraception.
- You are willing and able to sign a consent form agreeing to take part.
Who may not be able to join:
- You have already been treated for your current depressive episode for more than 14 days with either lithium or cariprazine.
- You have had electroconvulsive therapy (ECT — a treatment using electrical stimulation) during your current depressive episode.
- You have scored above 6 on a scale used to measure symptoms of mania (MAS scale).
- You have a diagnosis of dementia.
- The trial doctor believes there is a high risk that you may not be able to stick to the treatment plan.
- You are not able to understand the Danish language, as judged by the trial doctor.
- You are currently under any form of involuntary psychiatric treatment, such as forced hospital admission, or have been ordered into forensic psychiatric care by a court.
- You are currently experiencing significant delusions, hallucinations, or other psychotic symptoms, as assessed by the trial doctor.
- You have expressed certain levels of suicidal thoughts or intentions, as measured by a standard assessment tool (C-SSRS), or as judged by the trial doctor.
- You have certain serious health conditions — such as cancer, kidney failure, epilepsy, or a deep brain stimulation device — that could affect the trial results or your safety (confirm with trial site).
- You currently have a harmful dependency on alcohol or drugs, as defined by standard diagnostic guidelines (DSM-5).
- You have a known allergy to any ingredient in either of the study medications.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: René E. Nielsen, Prof, MD,PhD, Psychiatry, Aalborg University Hospital
Phone: +45 25487706
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Hamilton Depressions scale, version 6 (HDS-6)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.